Lion Point Capital, LP ARQT Holdings History
Number of Shares
46,300.00
Current Holdings Value*
$724,130.00
% of Portfolio
4.62%
Total Estimate Gain
$167,212.00
% of Total Estimate Gain
35.62%
Lion Point Capital, LP's Arcutis Biotherapeutics Inc Holding Summary
As of 2025-03-31, Lion Point Capital, LP held 46,300.00 shares of Arcutis Biotherapeutics Inc(ARQT), totaling $724,130.00. This investment constitutes 4.62% of their stock portfolio, and Lion Point Capital, LP now holds 0.04% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.
The initial trade took place in 2024Q3. And since then Lion Point Capital, LP has made 2 purchases of ARQT, at an average price of $10.14, for a total of 46,300.00 shares. Based on historical transaction data and ARQT's current price of $13.75, Lion Point Capital, LP's estimated gain on his ARQT holdings is $167,212.00, reflecting a 35.62% gain to date.
Lion Point Capital, LP ARQT ($13.75) Holding Chart
Lion Point Capital, LP ARQT ($13.75) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1